SECTORAL ASSET MANAGEMENT INC Holdings

SECTORAL ASSET MANAGEMENT INC is an investment fund managing more than 507.58M US dollars. The largest holdings include UnitedHealth Group Incorporated, HealthEquity and BioMarin Pharmaceutical. In Q3 2022 the fund bought assets of total value of 64.14M US dollars and sold assets of total value of 41.6M US dollars.

$507.58M

portfolio value

+2.23%

quarter

-20.32%

1 year

+6.97%

3 years

-5.97%

5 years

SECTORAL ASSET MANAGEMENT INC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	204738000	442116000
Q2 2016	153484000	1219456000
Q3 2016	189553000	115118000
Q4 2016	156443000	242325000
Q1 2017	213014000	282707000
Q2 2017	218757000	157355000
Q3 2017	158357000	280938000
Q4 2017	182249000	152343000
Q1 2018	207319000	126425000
Q2 2018	160721000	190124000
Q3 2018	166205000	129823000
Q4 2018	8099000	178114000
Q1 2019	148296000	53568000
Q2 2019	38960000	53424000
Q3 2019	20793000	215295000
Q4 2019	249918000	155524000
Q1 2020	54415000	201603000
Q2 2020	633679000	69770000
Q3 2020	397647000	258919000
Q4 2020	470513000	165411000
Q1 2021	410163000	510729000
Q2 2021	317078000	417475000
Q3 2021	260160000	292797000
Q4 2021	106091000	624689000
Q1 2022	75814000	138945000
Q2 2022	70710000	116087000
Q3 2022	64139000	41604000

SECTORAL ASSET MANAGEMENT INC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Healthcare Plans UnitedHealth Group Incorporated Portfolio share: 3.30% Portfolio value: 16.72M Avg. open price: $295.39 Current price: $535.04 P/L: +81.13% Sold -7.79% shares Q3 2022	share	3.30%	16.72M	$295.39	$535.04	+81.13%	Sold -7.79% shares Q3 2022
Health Information Services HealthEquity, Inc. Portfolio share: 3.08% Portfolio value: 15.65M Avg. open price: $67.44 Current price: $67.73 P/L: +0.43% Sold -3.12% shares Q3 2022	share	3.08%	15.65M	$67.44	$67.73	+0.43%	Sold -3.12% shares Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 2.73% Portfolio value: 13.83M Avg. open price: $89.78 Current price: $103.53 P/L: +15.31% Bought +15.17% shares Q3 2022	share	2.73%	13.83M	$89.78	$103.53	+15.31%	Bought +15.17% shares Q3 2022
Health Information Services Evolent Health, Inc. Portfolio share: 2.63% Portfolio value: 13.37M Avg. open price: $12.26 Current price: $28.66 P/L: +133.85% Sold -5.10% shares Q2 2022	share	2.63%	13.37M	$12.26	$28.66	+133.85%	Sold -5.10% shares Q2 2022
Medical Devices Inari Medical, Inc. Portfolio share: 2.61% Portfolio value: 13.24M Avg. open price: $90.64 Current price: $71.11 P/L: -21.55% Sold -0.80% shares Q3 2022	share	2.61%	13.24M	$90.64	$71.11	-21.55%	Sold -0.80% shares Q3 2022
Medical Devices iRhythm Technologies, Inc. Portfolio share: 2.54% Portfolio value: 12.89M Avg. open price: $100.62 Current price: $102.75 P/L: +2.12% Bought +37.21% shares Q3 2022	share	2.54%	12.89M	$100.62	$102.75	+2.12%	Bought +37.21% shares Q3 2022
Health Information Services R1 RCM Inc. Portfolio share: 2.49% Portfolio value: 12.64M Avg. open price: $10.75 Current price: $10.11 P/L: -5.98% Bought +13.01% shares Q3 2022	share	2.49%	12.64M	$10.75	$10.11	-5.98%	Bought +13.01% shares Q3 2022
Biotechnology PTC Therapeutics, Inc. Portfolio share: 2.36% Portfolio value: 11.99M Avg. open price: $29.64 Current price: $41.12 P/L: +38.74% Sold -0.42% shares Q3 2022	share	2.36%	11.99M	$29.64	$41.12	+38.74%	Sold -0.42% shares Q3 2022
Biotechnology Arvinas, Inc. Portfolio share: 2.19% Portfolio value: 11.10M Avg. open price: $46.06 Current price: $39.53 P/L: -14.17% Sold -6.53% shares Q3 2022	share	2.19%	11.10M	$46.06	$39.53	-14.17%	Sold -6.53% shares Q3 2022
Drug Manufacturers—General Johnson & Johnson Portfolio share: 2.18% Portfolio value: 11.08M Avg. open price: $120.19 Current price: $178.78 P/L: +48.75% Sold -6.74% shares Q2 2022	share	2.18%	11.08M	$120.19	$178.78	+48.75%	Sold -6.74% shares Q2 2022
Biotechnology Insmed Incorporated Portfolio share: 2.18% Portfolio value: 11.07M Avg. open price: $32.73 Current price: $19.89 P/L: -39.24% Sold -0.28% shares Q3 2022	share	2.18%	11.07M	$32.73	$19.89	-39.24%	Sold -0.28% shares Q3 2022
Diagnostics & Research ICON Public Limited Company Portfolio share: 1.95% Portfolio value: 9.91M Avg. open price: $226.93 Current price: $204.76 P/L: -9.77% Bought +50.04% shares Q3 2022	share	1.95%	9.91M	$226.93	$204.76	-9.77%	Bought +50.04% shares Q3 2022
Health Information Services Privia Health Group, Inc. Portfolio share: 1.83% Portfolio value: 9.30M Avg. open price: N/A Current price: $23.52 P/L: N/A Sold -8.08% shares Q3 2022	share	1.83%	9.30M	N/A	$23.52	N/A	Sold -8.08% shares Q3 2022
Medical Instruments & Supplies AtriCure, Inc. Portfolio share: 1.74% Portfolio value: 8.85M Avg. open price: $37.24 Current price: $43.65 P/L: +17.22% Sold -0.88% shares Q3 2022	share	1.74%	8.85M	$37.24	$43.65	+17.22%	Sold -0.88% shares Q3 2022
Biotechnology Exelixis, Inc. Portfolio share: 1.71% Portfolio value: 8.67M Avg. open price: $22.65 Current price: $17.22 P/L: -23.97% Bought +44.47% shares Q3 2022	share	1.71%	8.67M	$22.65	$17.22	-23.97%	Bought +44.47% shares Q3 2022
Diagnostics & Research Syneos Health, Inc. Portfolio share: 1.70% Portfolio value: 8.62M Avg. open price: $85.15 Current price: $34.66 P/L: -59.29% Bought +19.74% shares Q3 2022	share	1.70%	8.62M	$85.15	$34.66	-59.29%	Bought +19.74% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 1.67% Portfolio value: 8.46M Avg. open price: $25.77 Current price: $49.41 P/L: +91.74% Sold -19.09% shares Q3 2022	share	1.67%	8.46M	$25.77	$49.41	+91.74%	Sold -19.09% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 1.62% Portfolio value: 8.23M Avg. open price: $205.88 Current price: $243.11 P/L: +18.08% Sold -4.52% shares Q3 2022	share	1.62%	8.23M	$205.88	$243.11	+18.08%	Sold -4.52% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 1.60% Portfolio value: 8.13M Avg. open price: $66.03 Current price: $56.01 P/L: -15.17% Bought +30.44% shares Q3 2022	share	1.60%	8.13M	$66.03	$56.01	-15.17%	Bought +30.44% shares Q3 2022
Medical Devices Axonics, Inc. Portfolio share: 1.59% Portfolio value: 8.05M Avg. open price: $62.6 Current price: $67.47 P/L: +7.78% Sold -3.67% shares Q3 2022	share	1.59%	8.05M	$62.6	$67.47	+7.78%	Sold -3.67% shares Q3 2022
AGILITI INC Portfolio share: 1.57% Portfolio value: 7.98M Avg. open price: N/A Current price: N/A P/L: N/A Bought +25.83% shares Q3 2022	share	1.57%	7.98M	N/A	N/A	N/A	Bought +25.83% shares Q3 2022
Biotechnology Denali Therapeutics Inc. Portfolio share: 1.47% Portfolio value: 7.46M Avg. open price: $55.33 Current price: $30.94 P/L: -44.09% Bought +20.41% shares Q3 2022	share	1.47%	7.46M	$55.33	$30.94	-44.09%	Bought +20.41% shares Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 1.46% Portfolio value: 7.41M Avg. open price: $65.28 Current price: $234.96 P/L: +259.91% Sold -19.07% shares Q3 2022	share	1.46%	7.41M	$65.28	$234.96	+259.91%	Sold -19.07% shares Q3 2022
Biotechnology Blueprint Medicines Corporation Portfolio share: 1.43% Portfolio value: 7.24M Avg. open price: $73.47 Current price: $50.19 P/L: -31.69% Bought +34.19% shares Q3 2022	share	1.43%	7.24M	$73.47	$50.19	-31.69%	Bought +34.19% shares Q3 2022
Drug Manufacturers—General AbbVie Inc. Portfolio share: 1.40% Portfolio value: 7.12M Avg. open price: $97.37 Current price: $163.96 P/L: +68.39% Bought +31.64% shares Q3 2022	share	1.40%	7.12M	$97.37	$163.96	+68.39%	Bought +31.64% shares Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 1.28% Portfolio value: 6.48M Avg. open price: $4.3 Current price: $10.02 P/L: +132.88% Bought +22.54% shares Q3 2022	share	1.28%	6.48M	$4.3	$10.02	+132.88%	Bought +22.54% shares Q3 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 1.26% Portfolio value: 6.41M Avg. open price: N/A Current price: $12.33 P/L: N/A N/A Q3 2022	share	1.26%	6.41M	N/A	$12.33	N/A	N/A Q3 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 1.21% Portfolio value: 6.15M Avg. open price: $24.23 Current price: $20.01 P/L: -17.42% Bought +7.63% shares Q3 2022	share	1.21%	6.15M	$24.23	$20.01	-17.42%	Bought +7.63% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 1.20% Portfolio value: 6.09M Avg. open price: N/A Current price: $37.72 P/L: N/A Sold -40.17% shares Q3 2022	share	1.20%	6.09M	N/A	$37.72	N/A	Sold -40.17% shares Q3 2022
Biotechnology Amicus Therapeutics, Inc. Portfolio share: 1.18% Portfolio value: 5.97M Avg. open price: $12.41 Current price: $12.37 P/L: -0.36% Bought +2.10% shares Q3 2022	share	1.18%	5.97M	$12.41	$12.37	-0.36%	Bought +2.10% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 1.17% Portfolio value: 5.95M Avg. open price: $84.42 Current price: $369.29 P/L: +337.43% Sold -35.31% shares Q2 2022	share	1.17%	5.95M	$84.42	$369.29	+337.43%	Sold -35.31% shares Q2 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 1.17% Portfolio value: 5.93M Avg. open price: $34.13 Current price: $33.96 P/L: -0.51% Sold -27.18% shares Q3 2022	share	1.17%	5.93M	$34.13	$33.96	-0.51%	Sold -27.18% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 1.15% Portfolio value: 5.84M Avg. open price: $77.28 Current price: $98.48 P/L: +27.43% Bought +89.56% shares Q3 2022	share	1.15%	5.84M	$77.28	$98.48	+27.43%	Bought +89.56% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 1.14% Portfolio value: 5.78M Avg. open price: N/A Current price: $38.55 P/L: N/A N/A Q3 2022	share	1.14%	5.78M	N/A	$38.55	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 1.12% Portfolio value: 5.69M Avg. open price: $57.08 Current price: $54.25 P/L: -4.96% Bought +34.86% shares Q3 2022	share	1.12%	5.69M	$57.08	$54.25	-4.96%	Bought +34.86% shares Q3 2022
Drug Manufacturers—General Pfizer Inc. Portfolio share: 1.12% Portfolio value: 5.66M Avg. open price: $29.12 Current price: $50.73 P/L: +74.21% Sold -30.02% shares Q2 2022	share	1.12%	5.66M	$29.12	$50.73	+74.21%	Sold -30.02% shares Q2 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 1.11% Portfolio value: 5.63M Avg. open price: N/A Current price: $5.61 P/L: N/A N/A Q3 2022	share	1.11%	5.63M	N/A	$5.61	N/A	N/A Q3 2022
Biotechnology Silverback Therapeutics, Inc. Portfolio share: 1.09% Portfolio value: 5.51M Avg. open price: N/A Current price: $5.87 P/L: N/A N/A Q3 2022	share	1.09%	5.51M	N/A	$5.87	N/A	N/A Q3 2022
Biotechnology Halozyme Therapeutics, Inc. Portfolio share: 1.07% Portfolio value: 5.43M Avg. open price: $42.41 Current price: $55.94 P/L: +31.90% Bought +5.37% shares Q3 2022	share	1.07%	5.43M	$42.41	$55.94	+31.90%	Bought +5.37% shares Q3 2022
Healthcare Plans Humana Inc. Portfolio share: 1.06% Portfolio value: 5.39M Avg. open price: $446.26 Current price: $547.42 P/L: +22.67% Sold -21.79% shares Q3 2022	share	1.06%	5.39M	$446.26	$547.42	+22.67%	Sold -21.79% shares Q3 2022
Medical Devices Treace Medical Concepts, Inc. Portfolio share: 1.06% Portfolio value: 5.37M Avg. open price: $26.87 Current price: $24.44 P/L: -9.04% Sold -35.31% shares Q3 2022	share	1.06%	5.37M	$26.87	$24.44	-9.04%	Sold -35.31% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 1.03% Portfolio value: 5.23M Avg. open price: $66.48 Current price: $44.6 P/L: -32.91% Sold -29.02% shares Q2 2022	share	1.03%	5.23M	$66.48	$44.6	-32.91%	Sold -29.02% shares Q2 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 1.02% Portfolio value: 5.18M Avg. open price: $29.79 Current price: $25.51 P/L: -14.37% Bought +22.54% shares Q3 2022	share	1.02%	5.18M	$29.79	$25.51	-14.37%	Bought +22.54% shares Q3 2022
Medical Devices Silk Road Medical, Inc Portfolio share: 1.01% Portfolio value: 5.13M Avg. open price: $34.16 Current price: $53.65 P/L: +57.04% Sold -49.73% shares Q3 2022	share	1.01%	5.13M	$34.16	$53.65	+57.04%	Sold -49.73% shares Q3 2022
Medical Devices Abbott Laboratories Portfolio share: 0.99% Portfolio value: 5.00M Avg. open price: $89.23 Current price: $105.38 P/L: +18.10% Sold -8.81% shares Q3 2022	share	0.99%	5.00M	$89.23	$105.38	+18.10%	Sold -8.81% shares Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 0.98% Portfolio value: 4.97M Avg. open price: $48.98 Current price: $110.01 P/L: +124.59% Bought +14.93% shares Q1 2022	share	0.98%	4.97M	$48.98	$110.01	+124.59%	Bought +14.93% shares Q1 2022
Medical Devices Boston Scientific Corporation Portfolio share: 0.97% Portfolio value: 4.91M Avg. open price: $38.1 Current price: $45.42 P/L: +19.21% Bought +23.61% shares Q2 2022	share	0.97%	4.91M	$38.1	$45.42	+19.21%	Bought +23.61% shares Q2 2022
Drug Manufacturers—General Bristol-Myers Squibb Company Portfolio share: 0.92% Portfolio value: 4.65M Avg. open price: $53.66 Current price: $80.7 P/L: +50.40% Bought +79.45% shares Q3 2022	share	0.92%	4.65M	$53.66	$80.7	+50.40%	Bought +79.45% shares Q3 2022
Biotechnology Alnylam Pharmaceuticals, Inc. Portfolio share: 0.89% Portfolio value: 4.54M Avg. open price: $93.57 Current price: $226.4 P/L: +141.95% Bought +88.53% shares Q3 2022	share	0.89%	4.54M	$93.57	$226.4	+141.95%	Bought +88.53% shares Q3 2022
Medical Instruments & Supplies STAAR Surgical Company Portfolio share: 0.87% Portfolio value: 4.40M Avg. open price: $133.82 Current price: $62.33 P/L: -53.42% Bought +32.14% shares Q4 2021	share	0.87%	4.40M	$133.82	$62.33	-53.42%	Bought +32.14% shares Q4 2021
Health Information Services Signify Health, Inc. Portfolio share: 0.86% Portfolio value: 4.37M Avg. open price: N/A Current price: $28.65 P/L: N/A N/A Q3 2022	share	0.86%	4.37M	N/A	$28.65	N/A	N/A Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 0.86% Portfolio value: 4.34M Avg. open price: N/A Current price: $226.95 P/L: N/A Sold -19.61% shares Q3 2022	share	0.86%	4.34M	N/A	$226.95	N/A	Sold -19.61% shares Q3 2022
Biotechnology Rocket Pharmaceuticals, Inc. Portfolio share: 0.85% Portfolio value: 4.32M Avg. open price: $46.26 Current price: $19.03 P/L: -58.86% Sold -10.92% shares Q2 2022	share	0.85%	4.32M	$46.26	$19.03	-58.86%	Sold -10.92% shares Q2 2022
Biotechnology Arcutis Biotherapeutics, Inc. Portfolio share: 0.83% Portfolio value: 4.22M Avg. open price: $21.31 Current price: $17.35 P/L: -18.58% Bought +22.76% shares Q3 2022	share	0.83%	4.22M	$21.31	$17.35	-18.58%	Bought +22.76% shares Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 0.82% Portfolio value: 4.15M Avg. open price: $135.68 Current price: $92.75 P/L: -31.64% Sold -13.26% shares Q3 2022	share	0.82%	4.15M	$135.68	$92.75	-31.64%	Sold -13.26% shares Q3 2022
Biotechnology Fate Therapeutics, Inc. Portfolio share: 0.81% Portfolio value: 4.10M Avg. open price: $88.5 Current price: $20.4 P/L: -76.95% Sold -5.26% shares Q2 2022	share	0.81%	4.10M	$88.5	$20.4	-76.95%	Sold -5.26% shares Q2 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.80% Portfolio value: 4.05M Avg. open price: $7.82 Current price: $5.43 P/L: -30.60% Sold -9.73% shares Q3 2022	share	0.80%	4.05M	$7.82	$5.43	-30.60%	Sold -9.73% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.80% Portfolio value: 4.04M Avg. open price: $36.81 Current price: $38.12 P/L: +3.56% Sold -0.65% shares Q3 2022	share	0.80%	4.04M	$36.81	$38.12	+3.56%	Sold -0.65% shares Q3 2022
Biotechnology Intellia Therapeutics, Inc. Portfolio share: 0.79% Portfolio value: 3.99M Avg. open price: $133.32 Current price: $42.01 P/L: -68.49% Sold -1.14% shares Q2 2022	share	0.79%	3.99M	$133.32	$42.01	-68.49%	Sold -1.14% shares Q2 2022
Diagnostics & Research IQVIA Holdings Inc. Portfolio share: 0.72% Portfolio value: 3.67M Avg. open price: $216.99 Current price: $211.93 P/L: -2.33% Bought +26.88% shares Q3 2022	share	0.72%	3.67M	$216.99	$211.93	-2.33%	Bought +26.88% shares Q3 2022
Drug Manufacturers—General Amgen Inc. Portfolio share: 0.72% Portfolio value: 3.65M Avg. open price: $144.06 Current price: $285.01 P/L: +97.84% Sold -0.43% shares Q3 2022	share	0.72%	3.65M	$144.06	$285.01	+97.84%	Sold -0.43% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 0.70% Portfolio value: 3.54M Avg. open price: $84.13 Current price: $86.35 P/L: +2.64% Sold -5.10% shares Q3 2022	share	0.70%	3.54M	$84.13	$86.35	+2.64%	Sold -5.10% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.70% Portfolio value: 3.53M Avg. open price: $304.63 Current price: $292.75 P/L: -3.90% Sold -1.85% shares Q3 2022	share	0.70%	3.53M	$304.63	$292.75	-3.90%	Sold -1.85% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.68% Portfolio value: 3.43M Avg. open price: $11.7 Current price: $11.09 P/L: -5.21% Bought +79.40% shares Q3 2022	share	0.68%	3.43M	$11.7	$11.09	-5.21%	Bought +79.40% shares Q3 2022
Biotechnology Rallybio Corporation Portfolio share: 0.67% Portfolio value: 3.37M Avg. open price: $9.7 Current price: $5.35 P/L: -44.85% Sold -32.42% shares Q3 2022	share	0.67%	3.37M	$9.7	$5.35	-44.85%	Sold -32.42% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.67% Portfolio value: 3.37M Avg. open price: $106.77 Current price: $121.22 P/L: +13.53% Sold -24.16% shares Q3 2022	share	0.67%	3.37M	$106.77	$121.22	+13.53%	Sold -24.16% shares Q3 2022
Biotechnology Arrowhead Pharmaceuticals, Inc. Portfolio share: 0.64% Portfolio value: 3.26M Avg. open price: $67.35 Current price: $31.87 P/L: -52.68% Sold -15.41% shares Q3 2022	share	0.64%	3.26M	$67.35	$31.87	-52.68%	Sold -15.41% shares Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 0.62% Portfolio value: 3.13M Avg. open price: N/A Current price: $44.37 P/L: N/A N/A Q3 2022	share	0.62%	3.13M	N/A	$44.37	N/A	N/A Q3 2022
Diagnostics & Research Thermo Fisher Scientific Inc. Portfolio share: 0.58% Portfolio value: 2.96M Avg. open price: $373.35 Current price: $557.21 P/L: +49.25% Sold -65.08% shares Q2 2022	share	0.58%	2.96M	$373.35	$557.21	+49.25%	Sold -65.08% shares Q2 2022
Medical Devices Medtronic plc Portfolio share: 0.50% Portfolio value: 2.54M Avg. open price: $86.9 Current price: $78.79 P/L: -9.33% Bought +23.48% shares Q3 2022	share	0.50%	2.54M	$86.9	$78.79	-9.33%	Bought +23.48% shares Q3 2022
Biotechnology Olema Pharmaceuticals, Inc. Portfolio share: 0.48% Portfolio value: 2.43M Avg. open price: $33.18 Current price: $2.79 P/L: -91.59% N/A Q3 2022	share	0.48%	2.43M	$33.18	$2.79	-91.59%	N/A Q3 2022
Health Information Services Certara, Inc. Portfolio share: 0.45% Portfolio value: 2.29M Avg. open price: N/A Current price: $17.72 P/L: N/A Sold -32.26% shares Q2 2022	share	0.45%	2.29M	N/A	$17.72	N/A	Sold -32.26% shares Q2 2022
Biotechnology Vertex Pharmaceuticals Incorporated Portfolio share: 0.45% Portfolio value: 2.29M Avg. open price: $135.89 Current price: $317.6 P/L: +133.72% Sold -2.46% shares Q3 2022	share	0.45%	2.29M	$135.89	$317.6	+133.72%	Sold -2.46% shares Q3 2022
Biotechnology Regeneron Pharmaceuticals, Inc. Portfolio share: 0.45% Portfolio value: 2.28M Avg. open price: $420.99 Current price: $755.45 P/L: +79.44% Bought +3.43% shares Q3 2022	share	0.45%	2.28M	$420.99	$755.45	+79.44%	Bought +3.43% shares Q3 2022
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 0.44% Portfolio value: 2.24M Avg. open price: $67.33 Current price: $87.98 P/L: +30.67% Bought +45.60% shares Q2 2022	share	0.44%	2.24M	$67.33	$87.98	+30.67%	Bought +45.60% shares Q2 2022
Diagnostics & Research Danaher Corporation Portfolio share: 0.44% Portfolio value: 2.22M Avg. open price: $221.6 Current price: $267.97 P/L: +20.92% Sold -42.79% shares Q2 2022	share	0.44%	2.22M	$221.6	$267.97	+20.92%	Sold -42.79% shares Q2 2022
Healthcare Plans CIGNA CORP Portfolio share: 0.43% Portfolio value: 2.16M Avg. open price: $168.31 Current price: $327.39 P/L: +94.51% Sold -26.76% shares Q2 2022	share	0.43%	2.16M	$168.31	$327.39	+94.51%	Sold -26.76% shares Q2 2022
Biotechnology Moderna, Inc. Portfolio share: 0.43% Portfolio value: 2.16M Avg. open price: $48.93 Current price: $175.93 P/L: +259.54% Bought +1.11% shares Q3 2022	share	0.43%	2.16M	$48.93	$175.93	+259.54%	Bought +1.11% shares Q3 2022
Medical Devices Stryker Corporation Portfolio share: 0.41% Portfolio value: 2.10M Avg. open price: $243.24 Current price: $237.9 P/L: -2.20% N/A Q3 2022	share	0.41%	2.10M	$243.24	$237.9	-2.20%	N/A Q3 2022
Healthcare Plans Molina Healthcare, Inc. Portfolio share: 0.41% Portfolio value: 2.07M Avg. open price: $76.59 Current price: $335.11 P/L: +337.55% Sold -38.93% shares Q3 2022	share	0.41%	2.07M	$76.59	$335.11	+337.55%	Sold -38.93% shares Q3 2022
Healthcare Plans Elevance Health Inc. Portfolio share: 0.38% Portfolio value: 1.93M Avg. open price: N/A Current price: $522.34 P/L: N/A Sold -22.73% shares Q3 2022	share	0.38%	1.93M	N/A	$522.34	N/A	Sold -22.73% shares Q3 2022
Biotechnology eFFECTOR Therapeutics, Inc. Portfolio share: 0.27% Portfolio value: 1.36M Avg. open price: N/A Current price: $0.43 P/L: N/A Sold -0.00% shares Q2 2022	share	0.27%	1.36M	N/A	$0.43	N/A	Sold -0.00% shares Q2 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 0.26% Portfolio value: 1.3M Avg. open price: $48.02 Current price: $20.26 P/L: -57.81% N/A Q3 2022	share	0.26%	1.3M	$48.02	$20.26	-57.81%	N/A Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 0.21% Portfolio value: 1.07M Avg. open price: $52.45 Current price: $68.42 P/L: +30.44% Bought +18.89% shares Q3 2022	share	0.21%	1.07M	$52.45	$68.42	+30.44%	Bought +18.89% shares Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 0.17% Portfolio value: 881K Avg. open price: $239.89 Current price: $213.86 P/L: -10.85% Bought +35.09% shares Q3 2022	share	0.17%	881K	$239.89	$213.86	-10.85%	Bought +35.09% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.16% Portfolio value: 797K Avg. open price: N/A Current price: $21.42 P/L: N/A N/A Q3 2022	share	0.16%	797K	N/A	$21.42	N/A	N/A Q3 2022
Biotechnology BeiGene, Ltd. Portfolio share: 0.15% Portfolio value: 779K Avg. open price: $175.81 Current price: $188.71 P/L: +7.34% Bought +13.78% shares Q3 2022	share	0.15%	779K	$175.81	$188.71	+7.34%	Bought +13.78% shares Q3 2022
Biotechnology Royalty Pharma plc Portfolio share: 0.10% Portfolio value: 488K Avg. open price: N/A Current price: $43.01 P/L: N/A Sold -12.28% shares Q3 2022	share	0.10%	488K	N/A	$43.01	N/A	Sold -12.28% shares Q3 2022
Biotechnology Zai Lab Limited Portfolio share: 0.09% Portfolio value: 479K Avg. open price: $87.25 Current price: $33.74 P/L: -61.33% Bought +16.67% shares Q2 2022	share	0.09%	479K	$87.25	$33.74	-61.33%	Bought +16.67% shares Q2 2022
Biotechnology Incyte Corporation Portfolio share: 0.09% Portfolio value: 472K Avg. open price: $87 Current price: $84.08 P/L: -3.36% Bought +20.82% shares Q2 2022	share	0.09%	472K	$87	$84.08	-3.36%	Bought +20.82% shares Q2 2022
Drug Manufacturers—Specialty & Generic Dr. Reddy's Laboratories Limited Portfolio share: 0.09% Portfolio value: 471K Avg. open price: $42.8 Current price: $54.79 P/L: +28.02% Bought +5.88% shares Q3 2022	share	0.09%	471K	$42.8	$54.79	+28.02%	Bought +5.88% shares Q3 2022
Biotechnology argenx SE Portfolio share: 0.09% Portfolio value: 448K Avg. open price: N/A Current price: $393.21 P/L: N/A N/A Q2 2022	share	0.09%	448K	N/A	$393.21	N/A	N/A Q2 2022
Biotechnology United Therapeutics Corporation Portfolio share: 0.08% Portfolio value: 401K Avg. open price: N/A Current price: $273.72 P/L: N/A N/A Q2 2022	share	0.08%	401K	N/A	$273.72	N/A	N/A Q2 2022
Biotechnology Legend Biotech Corporation Portfolio share: 0.07% Portfolio value: 367K Avg. open price: $49.77 Current price: $50.99 P/L: +2.45% Sold -10.00% shares Q3 2022	share	0.07%	367K	$49.77	$50.99	+2.45%	Sold -10.00% shares Q3 2022
Biotechnology BioNTech SE Portfolio share: 0.07% Portfolio value: 364K Avg. open price: $246.69 Current price: $166.71 P/L: -32.42% Bought +22.73% shares Q3 2022	share	0.07%	364K	$246.69	$166.71	-32.42%	Bought +22.73% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 0.07% Portfolio value: 338K Avg. open price: N/A Current price: $44.93 P/L: N/A Sold -24.47% shares Q3 2022	share	0.07%	338K	N/A	$44.93	N/A	Sold -24.47% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 0.06% Portfolio value: 324K Avg. open price: $55.2 Current price: $124 P/L: +124.62% N/A Q2 2022	share	0.06%	324K	$55.2	$124	+124.62%	N/A Q2 2022
Biotechnology Jasper Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 316K Avg. open price: $3.55 Current price: $0.58 P/L: -83.65% Sold -44.08% shares Q3 2022	share	0.06%	316K	$3.55	$0.58	-83.65%	Sold -44.08% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 0.06% Portfolio value: 310K Avg. open price: $63.62 Current price: $122.96 P/L: +93.28% N/A Q2 2022	share	0.06%	310K	$63.62	$122.96	+93.28%	N/A Q2 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 0.05% Portfolio value: 263K Avg. open price: N/A Current price: $150.97 P/L: N/A N/A Q2 2022	share	0.05%	263K	N/A	$150.97	N/A	N/A Q2 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.05% Portfolio value: 257K Avg. open price: $71.3 Current price: $51.95 P/L: -27.14% Sold -92.70% shares Q4 2021	share	0.05%	257K	$71.3	$51.95	-27.14%	Sold -92.70% shares Q4 2021
Biotechnology Ionis Pharmaceuticals, Inc. Portfolio share: 0.04% Portfolio value: 197K Avg. open price: $61.93 Current price: $38.98 P/L: -37.06% N/A Q2 2022	share	0.04%	197K	$61.93	$38.98	-37.06%	N/A Q2 2022
Biotechnology Ascendis Pharma A/S Portfolio share: 0.04% Portfolio value: 195K Avg. open price: $131.53 Current price: $119.41 P/L: -9.21% Sold -69.16% shares Q2 2022	share	0.04%	195K	$131.53	$119.41	-9.21%	Sold -69.16% shares Q2 2022
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.03% Portfolio value: 172K Avg. open price: $2.49 Current price: $2.36 P/L: -5.22% Bought +50.00% shares Q3 2022	share	0.03%	172K	$2.49	$2.36	-5.22%	Bought +50.00% shares Q3 2022
Diagnostics & Research Medpace Holdings, Inc. Portfolio share: 0.03% Portfolio value: 167K Avg. open price: N/A Current price: $205.5 P/L: N/A N/A Q2 2022	share	0.03%	167K	N/A	$205.5	N/A	N/A Q2 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.03% Portfolio value: 163K Avg. open price: $42.41 Current price: $52.11 P/L: +22.87% Sold -23.85% shares Q2 2022	share	0.03%	163K	$42.41	$52.11	+22.87%	Sold -23.85% shares Q2 2022
Diagnostics & Research Agilent Technologies, Inc. Portfolio share: 0.03% Portfolio value: 140K Avg. open price: $126.62 Current price: $150.01 P/L: +18.47% Sold -8.01% shares Q3 2022	share	0.03%	140K	$126.62	$150.01	+18.47%	Sold -8.01% shares Q3 2022
Medical Instruments & Supplies NovoCure Limited Portfolio share: 0.02% Portfolio value: 122K Avg. open price: $69.5 Current price: $78 P/L: +12.23% Bought +14.29% shares Q3 2022	share	0.02%	122K	$69.5	$78	+12.23%	Bought +14.29% shares Q3 2022
Biotechnology Novavax, Inc. Portfolio share: 0.01% Portfolio value: 46K Avg. open price: $110.27 Current price: $17.61 P/L: -84.03% Sold -94.82% shares Q3 2022	share	0.01%	46K	$110.27	$17.61	-84.03%	Sold -94.82% shares Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $35.27 Current price: $13.34 P/L: -62.18% Sold -100.00% shares Q3 2022	share	0.00%	0	$35.27	$13.34	-62.18%	Sold -100.00% shares Q3 2022
Biotechnology Talaris Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $14.69 Current price: $1.42 P/L: -90.33% Sold -100.00% shares Q3 2022	share	0.00%	0	$14.69	$1.42	-90.33%	Sold -100.00% shares Q3 2022
Medical Devices Tandem Diabetes Care, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $84.46 Current price: $42.44 P/L: -49.75% Sold -100.00% shares Q3 2022	share	0.00%	0	$84.46	$42.44	-49.75%	Sold -100.00% shares Q3 2022
Health Information Services Convey Health Solutions Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.51 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.51	N/A	Sold -100.00% shares Q3 2022
Biotechnology iTeos Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $33.76 Current price: $20.04 P/L: -40.64% Sold -100.00% shares Q3 2022	share	0.00%	0	$33.76	$20.04	-40.64%	Sold -100.00% shares Q3 2022
Biotechnology Turning Point Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $52.15 Current price: $76.01 P/L: +45.75% Sold -100.00% shares Q3 2022	share	0.00%	0	$52.15	$76.01	+45.75%	Sold -100.00% shares Q3 2022
Biotechnology Ultragenyx Pharmaceutical Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $39.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$39.83	N/A	Sold -100.00% shares Q3 2022
Biotechnology Exscientia plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.51 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.51	N/A	Sold -100.00% shares Q3 2022
Biotechnology Vir Biotechnology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $26.57 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$26.57	N/A	Sold -100.00% shares Q3 2022
Biotechnology Mereo BioPharma Group plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.83	N/A	Sold -100.00% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $16.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$16.32	N/A	Sold -100.00% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $32.52 Current price: $9.4 P/L: -71.09% Sold -100.00% shares Q3 2022	share	0.00%	0	$32.52	$9.4	-71.09%	Sold -100.00% shares Q3 2022
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $18 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$18	N/A	Sold -100.00% shares Q3 2022

Showing TOP 122 SECTORAL ASSET MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SECTORAL ASSET MANAGEMENT INC?

The biggest position of the SECTORAL ASSET MANAGEMENT INC is UnitedHealth Group Incorporated (UNH) with 3.3% portfolio share worth of 16.73M US dollars.

Top 5 SECTORAL ASSET MANAGEMENT's holdings represent 14.35% of the portfolio:

UnitedHealth Group Incorporated (UNH) – 3.3%
HealthEquity, Inc. (HQY) – 3.08%
BioMarin Pharmaceutical Inc. (BMRN) – 2.73%
Evolent Health, Inc. (EVH) – 2.63%
Inari Medical, Inc. (NARI) – 2.61%

Who is the portfolio manager of SECTORAL ASSET MANAGEMENT INC?

The portfolio manager of the SECTORAL ASSET MANAGEMENT INC is .

What is the total asset value of the SECTORAL ASSET MANAGEMENT INC portfolio?

SECTORAL ASSET MANAGEMENT INC total asset value (portfolio value) is 507.58M US dollars.

Who is ?

is the portfolio manager of the SECTORAL ASSET MANAGEMENT INC.

What is (SECTORAL ASSET MANAGEMENT INC) fund performance?

SECTORAL ASSET MANAGEMENT's quarterly performance is +2.23%, annualy -20.32%. In the past 3 years, the value of 's portfolio has increased by +7%. In the past 5 years, the value of the portfolio has decreased by -6%.

What is the SECTORAL ASSET MANAGEMENT INC CIK?

SECTORAL ASSET MANAGEMENT's Central Index Key is 0001274413 .

SECTORAL ASSET MANAGEMENT INC Holdings

SECTORAL ASSET MANAGEMENT INC portfolio value:

SECTORAL ASSET MANAGEMENT INC quarter portfolio value change:

SECTORAL ASSET MANAGEMENT INC 1 year portfolio value change:

SECTORAL ASSET MANAGEMENT INC 3 years portfolio value change:

SECTORAL ASSET MANAGEMENT INC 5 years portfolio value change: